Position in JNJ
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$583,876
+$30,220 QoQ
Shares Held
2,299
+1.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.20%
of 13F equity value
Holder Rank
#3,554
of 4,676 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Quest 10 Wealth Builders, Inc. holds $1,239,103 across 11 Drug Manufacturers - General names. JNJ ranks #1 (47.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
2,299 | $583,876 | |
| 2 | ABBV |
AbbVie Inc.
|
1,355 | $340,972 | |
| 3 | LLY |
ELI LILLY & Co
|
109 | $130,737 | |
| 4 | MRK |
Merck & Co., Inc.
|
623 | $80,055 | |
| 5 | PFE |
Pfizer Inc
|
2,092 | $50,375 | |
| 6 | GSK |
GSK plc
|
239 | $12,528 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
97 | $12,254 | |
| 8 | AZN |
Astrazeneca PLC
|
61 | $11,566 |
All Filings in JNJ
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $583,876 | 2,299 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $553,656 | 2,265 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $242,545 | 1,172 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $235,112 | 1,268 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $190,937 | 1,250 | Shares | Sole | 2025-10-20 | |
| 2025-03-31 | $217,582 | 1,312 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $331,468 | 2,292 | Shares | Other | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||